Reimbursement Challenges and Solutions with Molecular Biomarker TestingVideo Categories: PMO Interview with the Innovator Series: Volume 12 and Video Library
Drs. Geoffrey Oxnard and Lauren Ritterhouse consider the current landscape of reimbursement for molecular biomarker testing, the need to run FDA-approved tests, and the role of CMS and local Medicare providers in testing reimbursement.
Dr Andrey Antov identifies situations in which people may want to consider genetic testing.
Emily Knight presents why quality of life is a big issue in polycythemia vera and how she helps patients in management Supported through funding from Incyte